Labviva Secures $20M in Series A Financing

Written By Daniel Webb

Labviva, the AI-driven life sciences digital marketplace that simplifies and scales purchasing processes, announced today that it has secured $20 million in Series A financing led by Biospring Partners, with participation from existing investors Senator Investment Group, B Capital Group, and Glasswing Ventures. The Series A funding brings the total amount raised since inception to $30 million.

Daniel Webb
Previous

Nsure.com Secures Strategic Investment from Pelican Ventures to Digitalize the Insurance Agency Industry
Next

Carbonwave raises $5M in Series A Funding